2015 Flashcards
Seminal emission depends on an intact:
- parasympathetic and somatic nervous system
- sympathetic nervous system
- parasympathetic nervous system
- sympathetic and parasympathetic nervous system
- sympathetic and somatic nervous systems.
2
Emission is defined as the deposition of seminal fluid into the posterior urethra by the vasa deferentia and the seminal vesicles. Ejaculation is the forceful expulsion of seminal fluid out the urethral meatus by contraction of the bulbospongiosus and ischiocavernosus muscles. Since the vasa and the seminal vesicles are innervated primarily by the sympathetic nervous system, emission is under control of the sympathetic nervous system. Alpha-adrenergic nerve stimulation causes not only contraction of the seminal vesicles and vasa deferentia but also closure of the bladder neck. Ejaculation is the result of somatic nerve stimulation of the periurethral striated musculature. The parasympathetic nervous system is not directly involved with either emission or ejaculation.
After starting antimicrobials in healthy individuals with uncomplicated acute pyelonephritis, the urine is typically sterile within:
- a few hours
- twenty-four hours
- forty-eight hours
- three days
- seven days.
1
The urine usually becomes sterile within a few hours of starting antibiotics even though fever, chills, and flank pain may continue for several days. A delay in clearance of bacteria may occur with obstruction, stone disease, anatomic abnormalities or impaired renal function. Symptoms of pyelonephritis continuing for 72 hours after initiation of culture appropriate antibiotics should result in the physician considering the need for imaging studies and repeat cultures to rule-out anatomic abnormalities or the emergence of antibiotic resistant bacteria.
A 55-year-old woman with breast cancer has a 3.5 cm right adrenal nodule. The nodule has an attenuation of 25 Hounsfield units on non-contrast CT scan, 80% washout on contrast enhanced CT scan, and signal loss of 40% on chemical shift MRI scan. The lesion is a:
- lipid rich adenoma
- lipid poor adenoma
- myelolipoma
- breast cancer metastasis
- primary adrenal cancer.
2
In patients with a history of cancer found to have a > 2 cm adrenal mass on a CT scan, approximately 50% of the lesions will be due to a metastasis from the primary tumor. Through the use of CT and MRI manipulations, the indeterminate adrenal mass (classified as a mass 2-5 cm in size) can usually be accurately characterized without biopsy. Benign adrenal tumors, such as a myelolipoma or lipid rich adenoma will usually have non-contrast CT Hounsfield units of < 10. In an adrenal lesion with a CT Hounsfield value of > 10, differentiation of lipid poor adenomas from malignant lesions will require a CT study with contrast and washout, as well as chemical shift MRI scans for differentiation of a benign from a malignant mass. The common features of lipid poor benign adenoma are > 60% washout on CT scan with I.V. contrast while a malignant lesion will usually have a < 60% washout on CT scan. MRI findings consistent with a lipid poor benign adenoma is an adrenal to spleen ratio (ASR) of < 70% and signal loss of > 20% on out of phase imaging. Malignant lesions will display an ASR of > 70% and signal loss of < 20% on out of phase imaging.
A 54-year-old man with hypertension and a creatinine of 1.7 mg/dl is started on an ACE inhibitor. After two weeks, the creatinine is unchanged, but hypertension persists and a diuretic is added. One week later, the creatinine is 2.5 mg/dl (eGFR of 27 ml/min/1.73 m2). The next test is:
- split renal vein renin measurements
- contrast-enhanced MR angiography
- nonenhanced MR angiography
- contrast-enhanced CT angiography
- captopril renography.
3
Up to 10% of patients with HTN may have an element of renal vascular disease as the etiology of their rise in blood pressure. In patients with bilateral renal artery disease, HTN is largely a volume-dependent phenomenon with excess fluid volume protecting renal function. When diuretics are given to these patients, volume depletion occurs, with renal perfusion subsequently becoming angiotensin-dependent. The combination of diuretics and ACE inhibitors in a patient with bilateral renal artery stenosis will therefore result in the onset of renal insufficiency. Based on this knowledge, the use of the combination of ACE inhibitors with diuretics may be used as a provocative test to identify patients with bilateral ischemic (renal vascular) nephropathy. In essence, a finding of an elevation in serum creatinine within two to four weeks of starting the combination of a diuretic and an ACE inhibitor is highly suggestive of the presence of bilateral renal artery stenosis. Screening for renal artery stenosis in this clinical scenario is mandatory.Captopril enhanced testing is less accurate in the setting of renal insufficiency and is not the test of choice in patients associated with an elevation in serum creatinine. Renin-based testing is mainly utilized to determine the possible presence of renovascular-induced HTN, and is not indicated once bilateral ischemic nephropathy has been suspected to be present by a provocative test using a diuretic and an ACE inhibitor.The key evaluation in this patient is the anatomical assessment of the renal arteries to determine the possibility for vascular intervention. Imaging studies used to diagnose renal artery stenosis include ultrasound, contrast-enhanced CT angiography, and contrast-enhanced or nonenhanced magnetic resonance (MR) angiography. Although ultrasound is an effective screening tool, visualization of the entire renal artery to assess for interventional repair can be problematic. Contrast-enhanced CT and MR angiography can provide exquisite details of the renal arterial anatomy, and are highly accurate for determining both the diagnosis and extent of renal artery stenosis. However, the use of iodinated contrast for CT or the gadolinium-based contrast for MR angiography may be problematic for patients with renal dysfunction, eGFR < 30 ml/min/BSA. In these patients, the iodinated CT contrast may potentially cause further kidney injury, and the use of gadolinium-based contrast can lead to a condition called nephrogenic systemic fibrosis (fibrosis of the skin, joints, and internal organs) that will lead to significant morbidity or death. The preferred test of choice in a patient with an eGFR of < 30 ml/min/BSA under consideration for surgical intervention is the use of nonenhanced MR angiography.
A 25-year-old man has left scrotal pain after sustaining an injury playing soccer. The left testis is tender and enlarged on exam. Scrotal ultrasound reveals a 5cm hematocele, normal intraparenchymal blood flow, and a focal area of increased left testis echogenicity. The tunica albuginea cannot be fully visualized. The next step is:
- observation
- MRI scan of the scrotum
- repeat scrotal ultrasound in 48 hours
- obtain tumor markers
- scrotal exploration.
5
The patient has a 5 cm hematocele following blunt scrotal trauma with an indeterminate ultrasound examination. Significant hematoceles (5 cm or greater) should be explored, regardless of imaging studies, as up to 80% will be associated with a testicular rupture. The increased area of echogenicity does not infer tumor, and thus, tumor markers are not indicated. MRI will not add useful information.
A 55-year-old active woman desires surgical repair of a vaginal bulge. She has urinary frequency but no urinary or fecal incontinence. The physical examination with a cystoscope in the urethra is shown followed by a cystogram at maximal Valsalva taken during a videourodynamic study. The next step is:
- anterior (cystocele) repair with sling
- transvaginal vault suspension and anterior (cystocele) repair
- uterosacral vault suspension and rectocele repair
- robotic sacrocolpopexy
- robotic sacrocolpopexy and midurethral sling.

5
This patient has vaginal vault prolapse. The image from the videourodynamics study does not demonstrate a cystocele. The majority of physicians would recommend that this patient should undergo repair of the vault prolapse with a concurrent anti-incontinence procedure. The concurrent anti-incontinence procedure is performed due to the increased risk of de novo stress incontinence following vault suspension. In the context of a robotic sacrocolpopexy, a midurethral sling would be the most appropriate approach. Urodynamics, with or without prolapse reduction, are not predictive of which patients will develop de novo SUI following vault suspension. While acceptable to proceed with robotic sacrocolpopexy and no sling, the patient should be informed of the risk of postoperative stress incontinence. Some patients may prefer this approach due to the inherent risks of sling procedure, however rare they may be.
During the third trimester of pregnancy, the most common changes in renal function tests are:
- elevated BUN; decreased creatinine
- elevated BUN; elevated creatinine
- decreased BUN; decreased creatinine
- decreased BUN; elevated creatinine
- unchanged BUN and creatinine.
3
In pregnancy, it has been proposed that the increase in cardiac output leads to increase in glomerular filtration rate (GFR) and renal plasma flow. GFR increases between 30-50% as full term approaches. This increase in GFR leads to a decrease in the serum BUN and creatinine. Therefore, the normal values for BUN and creatinine are lower in pregnant women than they are in non-pregnant women.
A 28-year-old man has 1 proteinuria and moderate blood on two dipstick analyses. Two microscopic urinalyses each reveals 0-2 RBC/hpf. According to the AUA Guidelines, the next step is:
- reassurance and no further evaluation
- serum albumin level
- urine cytology
- 24-hour urine collection for protein
- cystoscopy and upper tract imaging.
4
Proteinuria of 1 or greater on repetitive dipstick urinalyses should prompt a 24-hour collection to quantitate the degree of proteinuria. In the absence of significant bleeding, > 1 g/24 hour should then prompt a more extensive evaluation for renal parenchymal disease and possible nephrology referral. This patient in fact does not meet criteria of microhematuria because the number of RBCs/hpf is < 3 thus further hematuria evaluation is not warranted. Mild proteinuria would be unlikely to affect serum albumin levels.
A 68-year-old man with ESRD has been on peritoneal dialysis for four years. He is anuric and asymptomatic. Ultrasound reveals several non-echogenic cysts involving the left kidney. The next step is:
- left nephrectomy
- CT scan
- renal arteriography
- repeat ultrasound in six months
- conversion to hemodialysis.
4
The overall prevalence of RCC in patients with ESRD is 1%. This risk is increased three-four fold in individuals with acquired renal cystic disease of dialysis (ARCD). The onset of ARCD is directly related to the severity of azotemia and the length of time the individual has been on dialysis. RCC in patients with ESRD generally occurs within ten years of the initiation of dialysis. They are multicentric, bilateral, less aggressive than sporadic RCC, and have a male predominance. Both hemodialysis and peritoneal dialysis have been associated with an equivalent incidence of ARCD, and there is no evidence that conversion from one form of dialysis to another influences this disease. For this reason, periodic ultrasound is recommended every six months for patients on chronic dialysis for > 3 years. In this patient population it is appropriate to consider CT, MRI scan, or proceed directly to surgical intervention when the ultrasound suggests a complex cyst or a solid mass > 3 cm.
A 55-year-old man is scheduled to undergo TRUS-guided prostate biopsies. He has a severe allergy to ciprofloxacin. The best antibiotic regimen is:
- trimethoprim and sulfamethoxazole orally twice daily for three days
- cefuroxime 500 mg orally twice daily for three days
- levofloxacin 500 mg orally once daily for three days
- gentamicin 5 mg/kg IV 30 minutes prior to the biopsy
- ceftriaxone 1 gm I.V. 30 minutes prior to the biopsy.
5
TRUS and biopsy is one of the most common urologic procedures. Antibiotic prophylaxis is well-established as reducing infection after the procedure. The AUA Best Practice Statement on Antimicrobial Prophylaxis states that the only oral agent approved for TRUS and biopsy prophylaxis is an oral fluoroquinolone. Alternatives are an I.V. 1st, 2nd or 3d generation cephalosporin or aminoglycoside plus metronidazole or clindamycin. Septra and oral cefuroxime are incorrect because of the oral route of administration. Levofloxacin is incorrect since the patient had a severe ciprofloxacin allergy, so other fluoroquinolones should be avoided unless tolerance testing is performed. Gentamicin without metronidazole or clindamycin is also incorrect.
A 78-year-old woman with history of anaphylactic reaction to penicillin, renal insufficiency (Cr 2.3) has right-sided flank pain and high fever. Recent culture revealed E. coli with sensitivity to nitrofurantoin, gentamicin, ceftriaxone, and intermediate sensitivity to ciprofloxacin. The next step is to admit her to the hospital and start:
- ciprofloxacin
- gentamicin
- imipenem
- ceftriaxone with diphenhydramine and hydrocortisone
- ciprofloxacin and nitrofurantoin.
2
Aminoglycosides remain a mainstay of treatment for life-threatening gram negative infections. The risk of nephrotoxicity is increased in the elderly, diabetics, and in patients with pre-existing renal insufficiency. However, the acuity of this patient’s pyelonephritis makes those considerations secondary. Cephalosporins and beta-lactam antibiotics (imipenem) are generally contraindicated with a history of anaphylactic reaction to penicillin, even though the absolute risk of severe reaction appears to be quite low. There is no evidence that pre-treatment with diphenhydramine and hydrocortisone would further reduce this risk. Ciprofloxacin is not an ideal choice because the organism exhibits only intermediate sensitivity and antibiotic concentrations in the urine are lower in a kidney with markedly diminished function. Nitrofurantoin is only active in the urine and is not appropriate for the treatment of tissue infections.
A 17-year-old boy has a left radical orchiectomy for a pathologic T2 5 cm tumor, which is 70% embryonal cancer and 30% teratoma. He has a 2 cm para-aortic adenopathy and no other visible metastases. His initial markers show an AFP of 7,000 IU/ml and a normal beta-hCG. Two weeks later, his beta-hCG is normal and his AFP is 5,000 IU/ml. The next step is:
- repeat tumor markers in two weeks
- three cycles BEP
- four cycles etoposide and cisplatin
- four cycles of BEP
- RPLND.
4 T
his patient has T2N2M0S2 NSGCT, also categorized as clinical stage 2B. The standard treatment should be primary chemotherapy. The selection of chemotherapy regimen depends on the International Germ Cell Cancer Collaborative Group Risk Classification for Advanced Germ Cell Tumor (IGCCG) that includes location of primary tumor, metastases and tumor marker levels. This patient is considered intermediate risk based on the post orchiectomy AFP over 1,000 IU/ml, and all intermediate and high risk patients should receive four cycles of BEP.
A 46-year-old woman sustained a ureteral injury during an abdominal hysterectomy for fibroids six weeks ago. A left percutaneous nephrostomy tube was placed. A retrograde ureterogram and an antegrade pyeloureterogram are shown. The next step is:
- balloon dilation
- endoureterotomy
- ureteroureterostomy
- ureteral reimplant with psoas hitch
- ureteral reimplant with Boari flap.

4
The retrograde and antegrade studies show a complete obstruction of the left distal ureter at the level of the uterine vessels. Most likely, the ureter was divided during clamping of the left uterine vascular pedicle or a thermal injury was sustained. The high grade obstruction (no contrast goes through the obstruction with both retro and antegrade injections) demonstrated makes the success of an endoscopic approach unlikely. Ureteroureterostomy is not a good option in the distal ureter, and should be reserved for short mid- to upper ureteral defects. The best repair for this patient is a ureteral reimplant with a psoas hitch. A Boari flap is not necessary in this patient and is reserved for lengthy distal ureteral defects up to 15 cm long.
A 58-year-old man develops abdominal pain and fever to 101°F three days after left radical nephrectomy. He is treated with I.V. antibiotics. The next day, the previously dry incision leaks 100 ml of cloudy fluid (pH 9.5, amylase 8,000 U/l). CT scan shows a 5 cm fluid collection in the left renal fossa. The next step is a naso-gastric tube and:
- low triglyceride diet
- percutaneous drainage and TPN
- open surgical drainage
- open ligation of fistula site and drainage
- distal pancreatectomy and drainage.
2
A particularly distressing postoperative complication following radical nephrectomy is the development of a pancreatic fistula because of an unrecognized intraoperative injury to the pancreas. This is usually manifested in the immediate postoperative period with signs and symptoms of acute pancreatitis and drainage of alkaline fluid from the incision. A CT scan of the abdomen demonstrates a fluid collection in the retroperitoneum. Fluid draining from the incision should be analyzed for pH and the presence of amylase. Treatment involves percutaneous drainage of the pseudocyst or abscess. The majority of fistulae close spontaneously with the establishment of adequate drainage. Because the healing of a pancreatic fistula is usually a slow process associated with significant nutritional loss, the patient is also supported with hyperalimentation. Surgical treatment with resection of the distal pancreas is necessary if nonoperative management fails. Open surgical drainage or ligation of the fistula would not be indicated and/or considered the treatment of choice. A low triglyceride diet would be indicated for a lymphatic leak.
Cystine calculi can be diagnosed with the following test:
- sodium nitroprusside
- phenolphthalein
- thiazide challenge
- serum pH
- serum chloride.
1
The sodium nitroprusside spot test will turn urine purple in the presence of cystine. This test is used for screening purposes to identify patients with cystine stone disease who are undergoing a 24 hour urine collection for evaluation. Phenolphthalein is a urinary marker for laxative abuse and may be helpful in the diagnosis of ammonium acid urate stones. A thiazide challenge may be helpful in the diagnosis of hyperparathyroidism. Serum pH and serum chloride may be helpful in the diagnosis of RTA type I.
A 54-year-old man has a muscle invasive urothelial carcinoma on TURBT. The preoperative CT scan shows loss of the fat plane on the right side of the bladder. The next step is:
- PET scan
- MRI scan
- neoadjuvant chemotherapy
- XRT
- cystectomy.
3
This patient most likely has T3 or T4 disease based on this CT scan. For T2 to T4 disease, large prospective randomized trials and meta-analyses have demonstrated that outcomes are better in patients who receive neoadjuvant chemotherapy prior to surgery rather than surgery alone. There is no evidence that MRI is significantly better at determining whether there is organ confined disease than a CT scan. In addition, with a CT scan that is fairly unequivocal there is no benefit from additional local imaging.
The renal toxicity of intravenous contrast material is due to:
- glomerular injury
- afferent arteriolar constriction
- efferent arteriolar constriction
- intrarenal vasoconstriction and tubular necrosis
- efferent arteriolar dilation and tubular necrosis.
4
Contrast media accounts for 10% of all causes of hospital-acquired acute renal injury. Three key risk factors that may provoke this injury are: pre-existing renal dysfunction (serum creatinine > 1.6 mg/dl or eGFR < 60 ml/min/BSA), pre-existing diabetes, and reduced intravascular blood volume. Contrast agents evoke renal injury by two mechanisms: first, by acting as an intrarenal vasoconstricting agent resulting in decreased intrarenal blood flow and hypoxemia; second, by a direct toxic effect of the contrast agent on tubular epithelial cells. The combination of renal medullary ischemia and direct cellular toxicity leads to increased renal epithelial cell apoptosis and acute tubular necrosis. The osmolality of the contrast agent once believed to be of paramount importance in the induction of contrast-induced nephropathy has been shown to play a minimal role in contrast-induced nephropathy. Indeed, recent studies have found that viscosity of the contrast agent is more important than osmolality. These findings resulted in the recommendation that periprocedural hydration along with limiting the amount of contrast agent are the key to prevent contrast-induced renal failure. A recent meta-analysis to evaluate the various interventions employed for prevention of this complication, assessing sodium bicarbonate solutions, adenosine antagonists (theophylline), N-acetylcysteine and ascorbic acid noted mixed results with no definitive proof that these agents could prevent the complication. Randomized control studies have, however, shown that in patients with a creatinine of > 3.5 mg/dl prophylactic hemodialysis prior to and following the study can reduce the risk of this complication.
A 38-year old man is referred for prostate cancer screening. According to the AUA Guidelines, the next step is:
- advise against screening
- initiate yearly screening
- initiate yearly screening if positive family history or African American
- initiate biennial screening
- screen now and repeat in five years.
1
According to the EARLY DETECTION OF PROSTATE CANCER: AUA GUIDELINES, guideline statement number 1 states that the panel recommends against screening in all men under age 40. In this age group, there is a low prevalence of clinically detectable prostate cancer. There is no evidence to demonstrate a benefit of screening, and there are likely the same harms of screening as in other age groups. This recommendation holds even for African-Americans or those with a family history of prostate cancer. The panel does state that to reduce the harms of screening, a routine screening interval of two years (biennial screening) or more may be preferred over annual screening in those men who have participated in shared decision-making and decided on screening (Guideline statement 4). As compared to annual screening, it is expected that screening intervals of two years preserve the majority of the benefits and reduce over-diagnosis and false positives. However, in this patient population, no screening is recommended. Some authors have put forth the strategy of initial screening and then follow-up in five years. Although such strategies may help reduce over-diagnoses and better select men who are likely to be true positives, this approach has not been well-validated and accepted by the AUA Guidelines.
A 67-year-old man has a rectourethral fistula one year after cryotherapy for localized prostate cancer. An initial fulguration failed and six months ago, he underwent proximal colostomy and suprapubic tube placement. He continues to have urine leakage per rectum and recurrent UTIs. Biopsy of the prostate shows no cancer and serum PSA is 0.3 ng/ml. The best therapy is:
- pelvic exoneration
- transabdominal repair
- urinary diversion
- salvage prostatectomy
- York Mason transrectal, transsphincteric repair.
5
A rectourethral fistula is relatively low in the pelvis and is best managed by the posterior-transanal repair (York-Mason) approach, in which the posterior anal sphincter is split to provide good exposure of the anterior rectal wall. The fistula site can then be excised with a multilayer closure. A transabdominal repair is difficult in this setting due the location deep within the pelvis, and this type of fistula is better repaired through the posterior-transanal approach. A urinary diversion may need to be considered, but only if attempts for primary repair have failed. This patient’s PSA is <0.5 and he is likely to stay cancer free, so salvage prostatectomy or pelvic exoneration should not be considered.
A 76-year-old man with insulin dependent diabetes returns six years after artificial urinary sphincter (AUS) placement with difficulty emptying his bladder despite appropriate action of his control pump. Examination reveals perineal induration without fluctuance or tenderness. Urinalysis is normal and PVR is 250 cc. Urodynamics reveals low pressure voiding with incomplete emptying. Urethroscopy shows no evidence of erosion. The next step is:
- ciprofloxacin
- deactivate cuff
- initiate CIC
- pelvic CT scan
- remove AUS.
5
For late-onset urinary retention found in patients with an AUS in situ, endoscopic and urodynamic evaluation is required to identify urethral erosion, proximal obstruction, or the development of detrusor failure.In this case, obstructive voiding symptoms, an abnormal physical examination with a normal endoscopic and complete urodynamic evaluation are highly consistent with periprosthetic infection without urethral erosion, secondary pericuff edema resulting in the obstructive symptoms. Late infections of AUS are usually due to gram positive cocci (S. aureus or S. epidermidis). Treatment with ciprofloxacin will not clear the infection due to bacterial adherence to the biofilm of the AUS. In addition, in this patient with diabetes, the local infection could quickly escalate resulting in widespread cellulitis and Fournier’s gangrene. Removal of the AUS with appropriate cultures and, if indicated, salvage AUS replacement should be considered.Cuff deactivation will not prevent retention unless the patient is incapable of using the device. CIC will not treat the underlying problem, which remains undiagnosed. A pelvic CT scan may define inflammation around the device; however, a negative CT scan does not indicate absence of infection and, therefore, cannot be relied upon. Cuff size is not likely to influence voiding status except in the immediate postoperative period when, if retention occurs, cuff upsizing may be necessary. In this patient with a long history of an AUS, sub cuff atrophy is more likely.
In a testicular cancer patient, positron emission tomography (PET):
- has decreased sensitivity due to high cell turnover of germ cell tumors
- is most useful at the time of initial diagnosis
- is most useful in patients with lung nodules
- has good sensitivity for post-chemotherapy seminomas
- can distinguish teratoma versus fibrosis.
4
Malignant GCT accumulates fluorodeoxyglucose (FDG), and several studies have investigated FDG-labeled positron emission tomography (FDG-PET) in the staging of GCT at diagnosis and assessing response after chemotherapy. The high sensitivity is likely due to the high turnover and increased metabolic rate of GCTs. Due to limited sensitivity at the time of initial diagnosis, there is currently no role for FDG-PET in the routine evaluation of NSGCT and seminoma at the time of diagnosis. However, there may be a role for detection of recurrent disease and the assessment of residual masses after chemotherapy. For example, PET does appear to be a useful tool in seminoma patients when evaluating post-chemotherapy residual masses. In a series of seminoma patients who were evaluated post-chemotherapy for residual retroperitoneal masses, PET was accurate in 14/14 patients with tumors > 3 cm and in 22/23 patients with lesions < 3 cm. Overall, the sensitivity and specificity was 89% and 100%, respectively. The utility of FDG-PET in the prediction of retroperitoneal histology in NSGCT (particularly in the post-chemotherapy setting) is limited by the fact that teratoma is not FDG avid (likely due to the relatively low metabolic rate of teratomas). This likely accounts for the high false negative rates observed. Similarly, the utility of PET scanning in the immediate post-chemotherapy period appears to be limited. This is likely due to decreased metabolism and increased macrophage activity at that time, which compromises the accuracy of PET scanning. It is recommended that PET/CT be delayed for four to 12 weeks following completion of chemotherapy. There is no difference between abdominal and thoracic imaging using a PET scan in this setting.
A 62-year-old man develops penile pain three months after implantation of an inflatable penile prosthesis. He denies fever or chills. The prosthesis is functional and in excellent position. Tenderness is localized to the left corpus. WBC count and urinalysis are normal. The most likely cause of the penile pain is:
- oversized cylinder
- prosthetic erosion
- corporal fibrosis
- staphylococcal infection
- psychogenic.
4
Prosthetic infections occur in 1-3% of patients following inflatable penile implants with antibiotic coating, and usually occur within the first three months of implantation. The most common organism is staphylococcus, and infection occurs at the time of implantation. Pain without WBC count elevation or increase in erythrocyte sedimentation rate is common. The increasing nature of the pain is not consistent with post-operative pain or pain from a traumatic event. Prosthetic erosion would be apparent on physical exam. Corporal fibrosis is an uncommon late complication of penile prosthesis. An oversized cylinder is associated with buckling and pain with prosthetic inflation.
A 55-year-old man with a history of chronic bacterial prostatitis experiences urosepsis during induction chemotherapy for small cell lung cancer. Urine culture is positive for E. coli resistant to trimethoprim/sulfamethoxazole and ciprofloxacin; sensitive to nitrofurantoin, tobramycin, amikacin, and meropenem. Thorough urologic evaluation is normal except for documented persistence of the bacteria in the expressed prostatic secretions following a ten day course of I.V. meropenem. The next step is:
- observation
- nightly prophylaxis with oral nitrofurantoin
- daily intravesical tobramycin instillation
- IV tobramycin for six to eight weeks
- TURP.
2
Observation places the patient at risk of recurrent urosepsis. This can be prevented by continued nitrofurantoin prophylaxis which will prevent recurrent cystitis and symptomatic infection. I.V. tobramycin achieves poor penetration of the prostate and is unlikely to eradicate infection. Tobramycin instillations would be effective but are more invasive than oral prophylaxis. TURP would be inappropriate in this patient.
A 61-year-old woman underwent percutaneous cryoablation of a 2.4 cm renal mass one year ago. On follow-up imaging, the mass now measures 3 cm with some nodularity within the treatment zone. According to the AUA Guidelines, the next step is:
- repeat imaging in six months
- repeat imaging in one year
- PET scan
- percutaneous biopsy
- repeat cryoablation.
4
There is little long-term data on the cancer control of ablative procedures. Additionally, there is a well-recognized slow natural history of RCC in terms of growth rate. Thus, if imaging findings reveal increasing size, new nodularity, satellite lesions or failure of the treated lesion to regress over time even in the absence of enhancement, then the next step should be lesion biopsy. These findings would be concerning enough to warrant an intervention rather than routine imaging in 6-12 months. There is no data to support the routine use of PET scanning in the evaluation or follow-up of patients with small renal neoplasms, although ongoing studies with newer imaging agents are underway. Repeat ablation with no biopsy is also not indicated.

